{"Title": "Prognostic accuracy in second-line renal cancer therapy", "Year": 2015, "Source": "Lancet Oncol.", "Volume": "16", "Issue": 3, "Art.No": null, "PageStart": 240, "PageEnd": 241, "CitedBy": 0, "DOI": "10.1016/S1470-2045(15)70009-4", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84924980269&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Carcinoma, Renal Cell", "Decision Support Techniques", "Female", "Humans", "Kidney Neoplasms", "Male", "Molecular Targeted Therapy", "Salvage Therapy"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84924980269", "SubjectAreas": [["Oncology", "MEDI", "2730"]], "AuthorData": {"7004237921": {"Name": "Bex A.", "AuthorID": "7004237921", "AffiliationID": "60015205", "AffiliationName": "Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute"}}}